Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04074343
Title TAS-102 and Irinotecan in 2L+ Gastric and Gastroesophageal Adenocarcinoma
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors University of California, Irvine

gastroesophageal cancer

gastric adenocarcinoma


Irinotecan + Trifluridine-tipiracil hydrochloride

Age Groups: senior | adult
Covered Countries USA

No variant requirements are available.